NCT04609618View on ClinicalTrials.gov

Evaluatation of Appscent Device Safety and Effectiveness for Relief of Obstructive Sleep Apnea (OSA) Syndrome in Adults.

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

August 26, 2021

Study Completion Date

August 26, 2021

Conditions
Obstructive Sleep Apnea
Interventions
DEVICE

Appscent Device

computer-controlled, low pressure compressed air based, with disposable odorant capsules solution provided an odor environment at the nose,

Trial Locations (1)

Unknown

Sleep Lab, Tel Aviv

All Listed Sponsors
lead

Y.A. Appscent Ltd.

INDUSTRY

NCT04609618 - Evaluatation of Appscent Device Safety and Effectiveness for Relief of Obstructive Sleep Apnea (OSA) Syndrome in Adults. | Biotech Hunter | Biotech Hunter